Endothelial cells as mediators of vasodilation of arteries, J Cardiovasc Pharmacol, vol.6, issue.2, pp.336-343, 1984. ,
Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite, Science, vol.235, pp.473-476, 1987. ,
Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide, Proc Natl Acad Sci U S A, vol.82, pp.7738-7742, 1985. ,
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, vol.288, pp.373-376, 1980. ,
Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations, Proc Natl Acad Sci, vol.74, pp.3203-3207, 1977. ,
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide, Proc Natl Acad Sci, vol.84, pp.9265-9269, 1987. ,
Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain, Nature, vol.336, pp.385-388, 1988. ,
S-nitrosylation in health and disease, Trends Mol Med, vol.9, pp.160-168, 2003. ,
Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev, vol.43, pp.109-142, 1991. ,
Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly, J Geriatr Cardiol, vol.8, pp.230-242, 2011. ,
Nitric-Oxide -a Physiological Messenger Molecule, Annu Rev Biochem, vol.63, pp.175-195, 1994. ,
Nitric oxide synthase: models and mechanisms, Curr Opin Chem Biol, vol.4, pp.687-695, 2000. ,
Nitric oxide synthases: structure, function and inhibition, Biochem J, vol.357, pp.593-615, 2001. ,
Nitric-Oxide Synthases -Roles, Tolls, and Controls, Cell, vol.78, pp.915-918, 1994. ,
Nitric oxide signalling in cardiovascular health and disease, Nature Reviews Cardiology, vol.15, pp.292-316, 2018. ,
Nitric-Oxide and Cardiovascular Control, Exp Physiol, vol.78, pp.303-326, 1993. ,
Vascular endothelial cells synthesize nitric oxide from L-arginine, Nature, vol.333, pp.664-666, 1988. ,
Molecular Mechanisms of Nitric-Oxide Regulation -Potential Relevance to Cardiovascular-Disease, CircRes, vol.73, pp.217-222, 1993. ,
Nitric oxide and atherosclerosis: An update, Nitric Oxide-Biol Chem, vol.15, pp.265-279, 2006. ,
Nitric oxide and oxidative stress in vascular disease, Pflugers Arch, vol.459, pp.923-939, 2010. ,
Endothelial nitric oxide (NO) and its pathophysiologic regulation, Vasc Pharmacol, vol.49, pp.134-140, 2008. ,
Endothelial Function and Oxidative Stress in Cardiovascular Diseases, Circ J, vol.73, pp.411-418, 2009. ,
Nitric oxide in the pathogenesis of vascular disease, J Pathol, vol.190, pp.244-254, 2000. ,
Effects of S-Nitroso-Glutathione in the Human Forearm Circulation -Evidence for Selective-Inhibition of Platelet Activation, Cardiovasc Res, vol.28, pp.691-694, 1994. ,
Nitric Oxide Metabolites and Cardiovascular Disease: Markers, Mediators, or Both?, Journal of the American College of Cardiology, vol.47, pp.580-581, 2006. ,
Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling, Curr Opin Chem Biol, vol.16, pp.498-506, 2012. ,
S-Nitrosothiols: cellular formation and transport, Free Radical Biology and Medicine, vol.38, pp.831-838, 2005. ,
The biochemistry and physiology of S-nitrosothiols, Annu Rev Pharmacol Toxicol, vol.42, pp.585-600, 2002. ,
Nitric oxide and its role in the cardiovascular system, Prog Cardiovasc Dis, vol.38, pp.87-104, 1995. ,
Potential therapeutic uses for S-nitrosothiols, Clin Sci, vol.102, pp.99-105, 2002. ,
Nitric oxide donors: Chemical activities and biological applications, Chem Rev, vol.102, pp.1091-1134, 2002. ,
Nitric oxide release: Part II. Therapeutic applications, Chem Soc Rev, vol.41, pp.3742-3752, 2012. ,
Nitroglycerin--the first one hundred years: new facts about an old drug, J Pharm Pharmacol, vol.31, pp.801-809, 1979. ,
The use of inhaled nitric oxide in a wide variety of clinical problems, Pediatr Clin North Am, vol.45, pp.531-548, 1998. ,
, Drugs and Lactation Database (LactMed). National Library of Medicine (US): Bethesda (MD), 2006.
Sodium Nitroprusside as a Hyperinflation Drug and Therapeutic Alternatives, J Pharm Pract, vol.31, pp.374-381, 2018. ,
P-Nitrosophosphate compounds: new N-O heterodienophiles and nitroxyl delivery agents, J Org Chem, vol.65, pp.8725-8729, 2000. ,
Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta, Br J Pharmacol, vol.129, pp.315-322, 2000. ,
Venous versus arterial actions of diethylamine/nitric oxide (DEA/NO) complex and S-nitroso-N-acetylpenicillamine (SNAP) in vivo, Br J Pharmacol, vol.125, pp.1247-1251, 1998. ,
Neuroprotective effects of DETA-NONOate, a nitric oxide donor, on hydrogen peroxide-induced neurotoxicity in cortical neurones, Neuropharmacology, vol.38, pp.1307-1315, 1999. ,
Heterocyclic NO prodrugs, Farmaco, vol.54, pp.316-320, 1999. ,
Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide -An overview, CircRes, vol.90, pp.21-28, 2002. ,
Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin, J Pharmacol Exp Ther, vol.219, pp.181-186, 1981. ,
Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine, J Cyclic Nucleotide Res, vol.5, pp.211-224, 1979. ,
Inhibition of NADPH-cytochrome P450 reductase and glyceryl trinitrate biotransformation by diphenyleneiodonium sulfate, Biochem Pharmacol, vol.56, pp.881-893, 1998. ,
Nitroglycerin metabolism in vascular tissue: role of glutathione S-transferases and relationship between NO. and NO2-formation, Biochem J, vol.292, issue.2, pp.545-550, 1993. ,
Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance, J Clin Invest, vol.95, pp.187-194, 1995. ,
Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membranebound NADH oxidase. A new action for an old drug, J Clin Invest, vol.98, pp.1465-1470, 1996. ,
Urinary NItrotyrosine Content as a Marker of Peroxynitrite-induced Tolerance to Organic NItrates, J Cardiovasc Pharmacol Ther, vol.2, pp.85-96, 1997. ,
Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta, J Cardiovasc Pharmacol, vol.10, pp.371-378, 1987. ,
Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability, Circ Res, vol.86, pp.7-12, 2000. ,
Recent developments in the chemistry and in the biological applications of amidoximes, Curr Pharm Des, vol.14, pp.1001-1047, 2008. ,
Reduction of N-hydroxylated compounds: amidoximes (Nhydroxyamidines) as pro-drugs of amidines, Drug Metab Rev, vol.34, pp.565-579, 2002. ,
, Acta Crystallographica Section E, vol.63, pp.4698-4698, 2007.
S-Nitrosothiols: a class of nitric oxide-donor drugs, Clin Sci, vol.98, pp.507-520, 2000. ,
S-nitrosothiols and role of metal ions in decomposition to nitric oxide, Meth Enzymol, vol.268, pp.299-308, 1996. ,
Mechanism of nitric oxide release from S-nitrosothiols, J Biol Chem, vol.271, pp.18596-18603, 1996. ,
Visible light photochemical release of nitric oxide from S-nitrosoglutathione: potential photochemotherapeutic applications, Photochem Photobiol, vol.59, pp.463-467, 1994. ,
, Biochim Biophys Acta-Gen Subj, vol.1830, pp.3173-3181, 2013.
Biological chemistry and clinical potential of S-nitrosothiols, Free Radical Biology and Medicine, vol.28, pp.1478-1486, 2000. ,
The kinetics of S-transnitrosation--a reversible second-order reaction, Anal Biochem, vol.272, pp.257-262, 1999. ,
Equilibrium and kinetics studies of transnitrosation between S-nitrosothiols and thiols, Bioorg Med Chem Lett, vol.11, pp.433-436, 2001. ,
Synthesis, decomposition, and vasodilator action of some new S-nitrosated dipeptides, Nitric Oxide, vol.2, pp.193-202, 1998. ,
S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups, Curr Top Microbiol Immunol, vol.196, pp.19-36, 1995. ,
NO+, NO, and NO-donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation, Arch Biochem Biophys, vol.318, pp.279-285, 1995. ,
The role of glutathione in the transport and catabolism of nitric oxide, FEBS Lett, vol.382, pp.223-228, 1996. ,
Nitric oxide-induced Sglutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase, J Biol Chem, vol.274, pp.9427-9430, 1999. ,
S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione, Arch Biochem Biophys, vol.362, pp.67-78, 1999. ,
Cellular responses to nitric oxide: role of protein Sthiolation/dethiolation, Arch Biochem Biophys, vol.358, pp.232-242, 1998. ,
In vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance, J Pharmacol Exp Ther, vol.278, pp.1296-1305, 1996. ,
Current Developments in the Therapeutic Potential of S-Nitrosoglutathione, an Endogenous NO-Donor Molecule, Curr Pharm Biotechnol, vol.12, pp.1368-1374, 2011. ,
Some observations concerning the S-nitroso and S-phenylsulphonyl derivatives of L-cysteine and glutathione, Tetrahedron Letters, vol.26, pp.2013-2016, 1985. ,
Complete Physicochemical Identity Card of S-nitrosoglutathione, Current Pharmaceutical Analysis, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00807801
S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme, Biochem J, vol.331, pp.659-668, 1998. ,
Evidence for the identity of glutathione-dependent formaldehyde dehydrogenase and class III alcohol dehydrogenase, FEBS Lett, vol.257, pp.105-109, 1989. ,
Studies on reduction of S-nitrosoglutathione by human carbonyl reductases 1 and 3, Chem Biol Interact, vol.191, pp.95-103, 2011. ,
The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy, Crit Rev Biochem Mol Biol, vol.52, pp.340-354, 2017. ,
Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins, Science, vol.320, pp.1050-1054, 2008. ,
Thioredoxin and thioredoxin reductase in relation to reversible S-nitrosylation, Antioxid Redox Signal, vol.18, pp.259-269, 2013. ,
Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine, Nat Chem Biol, vol.1, pp.154-158, 2005. ,
Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide, J Clin Invest, vol.103, pp.393-399, 1999. ,
Characterization of the S-denitrosation activity of protein disulfide isomerase, J Biol Chem, vol.280, pp.8733-8741, 2005. ,
gamma-Glutamyl transpeptidase: kinetics and mechanism, Meth Enzymol, vol.113, pp.419-437, 1985. ,
Gamma-glutamyl transpeptidase, Meth Enzymol, vol.77, pp.237-253, 1981. ,
Gamma-glutamyl-glutathione. Natural occurrence and enzymology, J Biol Chem, vol.261, pp.13657-13661, 1986. ,
Seleno compounds and glutathione peroxidase catalyzed decomposition of S-nitrosothiols, Biochem Biophys Res Commun, vol.228, pp.88-93, 1996. ,
Xanthine oxidase-mediated decomposition of S-nitrosothiols, J Biol Chem, vol.273, pp.7828-7834, 1998. ,
Effect of superoxide dismutase on the stability of S-nitrosothiols, Arch Biochem Biophys, vol.361, pp.323-330, 1999. ,
Medium-and short-chain dehydrogenase/reductase gene and protein families : Dual functions of alcohol dehydrogenase 3: implications with focus on formaldehyde dehydrogenase and S-nitrosoglutathione reductase activities, Cell Mol Life Sci, vol.65, pp.3950-3960, 2008. ,
Systemic Effects of S-Nitroso-Glutathione in the Human Following Intravenous-Infusion, Br J Clin Pharmacol, vol.40, pp.101-102, 1995. ,
Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors, Arterioscler Thromb Vasc Biol, vol.16, pp.51-55, 1996. ,
Snitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo, Heart, vol.80, pp.146-150, 1998. ,
The effects of S-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia, Obstet Gynecol, vol.88, pp.14-19, 1996. ,
Inhibition of Platelet Activity by S-Nitrosoglutathione During Coronary Angioplasty, Lancet, vol.344, pp.1458-1460, 1994. ,
L-arginine and S-nitrosoglutathione reduce embolization in humans, Circulation, vol.103, pp.2371-2375, 2001. ,
S-nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty, Circulation, vol.106, pp.3057-3062, 2002. ,
S-nitrosoglutathione reduces the rate of embolization in humans, Circulation, vol.98, pp.1372-1375, 1998. ,
Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev, vol.43, pp.109-142, 1991. ,
Relative Potency and Arteriovenous Selectivity of Nitrovasodilators on Human Blood-Vessels -an Insight into the Targeting of Nitric-Oxide Delivery, J Pharmacol Exp Ther, vol.273, pp.154-160, 1995. ,
Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO -Experimental and clinical study on the fate of NO in human blood, CircRes, vol.91, pp.470-477, 2002. ,
The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension, Small, vol.11, pp.2291-2304, 2015. ,
Topically applied Snitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin, Br J Dermatol, vol.151, pp.977-983, 2004. ,
Characterization of Bronchodilator Effects and Fate of S-Nitrosothiols, J Pharmacol Exp Ther, vol.272, pp.1238-1245, 1995. ,
Stable S-nitrosthiol formulations, patent cooperation treaty, 2005. ,
Snitrosoglutathione incorporated in poly(ethylene glycol) matrix: potential use for topical nitric oxide delivery, Nitric Oxide-Biol Chem, vol.11, pp.263-272, 2004. ,
Solid films of blended poly(vinyl alcohol)/poly(vinyl pyrrolidone) for topical S-nitrosoglutathione and nitric oxide release, J Pharm Sci, vol.94, pp.994-1003, 2005. ,
Poly(vinyl alcohol) and poly(vinyl pyrrolidone) blended films for local nitric oxide release, Biomaterials, vol.25, pp.3773-3782, 2004. ,
Poly(vinyl alcohol) films for topical delivery of Snitrosoglutathione: effect of freezing-thawing on the diffusion properties, J Biomed Mater Res Part B Appl Biomater, vol.93, pp.416-424, 2010. ,
Nitric oxide-releasing chitosan film for enhanced antibacterial and in vivo wound-healing efficacy, Int J Biol Macromol, vol.79, pp.217-225, 2015. ,
In vivo evaluation of vaginal films for mucosal delivery of nitric oxide, Biomaterials, vol.30, pp.3978-3985, 2009. ,
Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in Pluronic F127 gel: potential uses for local and controlled nitric oxide release, Biomaterials, vol.24, pp.3543-3553, 2003. ,
Skin vasodilation and analgesic effect of a topical nitric oxide-releasing hydrogel, J Mater Sci Mater Med, vol.24, pp.2157-2169, 2013. ,
Topical Snitrosoglutathione-releasing hydrogel improves healing of rat ischaemic wounds, J Tissue Eng Regen Med, vol.5, pp.612-619, 2011. ,
S-nitrosoglutathione-containing chitosan nanoparticles dispersed in Pluronic F-127 hydrogel: Potential uses in topical applications, Journal of Drug Delivery Science and Technology, vol.43, pp.211-220, 2018. ,
S-Nitrosoglutathione loaded poly(lactic-co-glycolic acid) microparticles for prolonged nitric oxide release and enhanced healing of methicillin-resistant Staphylococcus aureus-infected wounds, Eur J Pharm Biopharm, vol.132, pp.94-102, 2018. ,
Nitric oxideeluting scaffolds and their interaction with smooth muscle cells in vitro, J Biomed Mater Res A, vol.103, pp.3303-3311, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01277820
, Situ Microparticles Loaded with S-Nitrosoglutathione Protect from Stroke, vol.10, p.144659, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01279697
Nitric oxide-eluting nanocomposite for cardiovascular implants, J Mater Sci Mater Med, vol.25, pp.917-929, 2014. ,
Optimization of cardiovascular stent against restenosis: factorial design-based statistical analysis of polymer coating conditions, PLoS ONE, vol.7, p.43100, 2012. ,
Polymeric nano-and microparticle technologies for oral gene delivery, Expert Opin Drug Deliv, vol.4, pp.197-213, 2007. ,
S-Nitrosoglutathione protects the spinal bladder: Novel therapeutic approach to post-spinal cord injury bladder remodeling: GSNO Protects Spinal Bladder, Neurourology and Urodynamics, vol.34, pp.519-526, 2015. ,
Preclinical Therapeutic Potential of a Nitrosylating Agent in the Treatment of Ovarian Cancer, PLoS ONE, vol.9, p.97897, 2014. ,
S-nitrosoglutathione a Physiologic Nitric Oxide Carrier Attenuates Experimental Autoimmune Encephalomyelitis, Journal of Neuroimmune Pharmacology, vol.5, pp.240-251, 2010. ,
S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP161-180)-induced experimental autoimmune uveitis, J Ocular Pharmacol Ther, vol.23, pp.221-231, 2007. ,
Time lasting Snitrosoglutathione polymeric nanoparticles delay cellular protein S-nitrosation, European Journal of Pharmaceutics and Biopharmaceutics, vol.89, pp.1-8, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01281136
Polymer nanocomposite particles of S -nitrosoglutathione: A suitable formulation for protection and sustained oral delivery, International Journal of Pharmaceutics, vol.495, pp.354-361, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01281137
Polymer nanocomposites enhance S -nitrosoglutathione intestinal absorption and promote the formation of releasable nitric oxide stores in rat aorta, Nanomedicine: Nanotechnology, Biology and Medicine, vol.12, pp.1795-1803, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01493332
Oral Drug Delivery with Polymeric Nanoparticles: The Gastrointestinal Mucus Barriers, Adv Drug Deliv Rev, vol.64, pp.557-570, 2012. ,
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art, Journal of Controlled Release, vol.240, pp.504-526, 2016. ,
Polymeric nanoparticles and microparticles for the delivery of peptides, biologics, and soluble therapeutics, Journal of Controlled Release, vol.219, pp.519-535, 2015. ,
Nanoparticles for oral delivery: Targeted nanoparticles with peptidic ligands for oral protein delivery, Adv Drug Deliv Rev, vol.65, pp.822-832, 2013. ,
Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review, J Control Release, vol.114, pp.1-14, 2006. ,
Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori, Biomacromolecules, vol.11, pp.133-142, 2010. ,
Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study, Nanomedicine (Lond), vol.10, pp.57-71, 2015. ,
VB12-coated Gel-Core-SLN containing insulin: Another way to improve oral absorption, Int J Pharm, vol.493, pp.451-459, 2015. ,
Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin, Acta Biomater, vol.31, pp.288-300, 2016. ,
Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting, Eur J Pharm Sci, vol.42, pp.11-18, 2011. ,
Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats, Nanomedicine, vol.8, pp.740-747, 2012. ,
pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model, J Pharm Sci, vol.103, pp.687-696, 2014. ,
Nanoparticles in drug delivery: Past, present and future, Advanced Drug Delivery Reviews, vol.65, pp.21-23, 2013. ,
Microparticles and nanoparticles for drug delivery, Biotechnology and Bioengineering, vol.96, pp.203-209, 2007. ,
Nanoparticles and Microparticles for the Delivery of Polypeptides and Proteins, Adv Drug Deliv Rev, vol.10, pp.141-162, 1993. ,
Nano and microparticles as controlled drug delivery devices, Journal of Pharmacy and Pharmaceutical Sciences, 2000. ,
Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-coglycolide) and its derivatives, J Control Release, vol.125, pp.193-209, 2008. ,
The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?, Clin Pharmacokinet, vol.41, pp.235-253, 2002. ,
Drug delivery to the small intestine, Curr Gastroenterol Rep, vol.6, pp.371-376, 2004. ,
Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats, J Pharmacol Exp Ther, vol.292, pp.433-439, 2000. ,
Regulation of the movement of solutes across tight junctions, Annu Rev Physiol, vol.60, pp.143-159, 1998. ,
Enhancement of colonic drug absorption by the paracellular permeation route, Pharm Res, vol.5, pp.341-346, 1988. ,
Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue, J Pharm Sci, vol.85, pp.165-169, 1996. ,
Physiological regulation of transepithelial impedance in the intestinal mucosa of rats and hamsters, J Membr Biol, vol.100, pp.137-148, 1987. ,
Ionic permeation mechanisms in epithelia: biionic potentials, dilution potentials, conductances, and streaming potentials, Meth Enzymol, vol.171, pp.678-715, 1989. ,
Barrier function of epithelia, Am J Physiol, vol.241, pp.275-288, 1981. ,
Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery, Expert Opin Drug Deliv, vol.1, pp.141-163, 2004. ,
B) Mechanisms of peptide and protein absorption: (2) Transcellular mechanism of peptide and protein absorption: passive aspects, Advanced Drug Delivery Reviews, vol.7, pp.365-385, 1991. ,
Issues in oral nanoparticle drug carrier uptake and targeting, J Drug Target, vol.12, pp.65-70, 2004. ,
Human intestinal M cells display the sialyl Lewis A antigen, Infect Immun, vol.67, pp.946-953, 1999. ,
Targeting of mucosal vaccines to Peyer's patch M cells, Behring Inst Mitt, pp.376-389, 1997. ,
Lectin-mediated mucosal delivery of drugs and microparticles, Adv Drug Deliv Rev, vol.43, pp.207-223, 2000. ,
Use of fluorescence imaging to investigate the structure and function of intestinal M cells, Adv Drug Deliv Rev, vol.57, pp.123-134, 2005. ,
Encyclopedia of controlled drug delivery, Polymer International, vol.1, pp.263-263, 1999. ,
Gastrointestinal absorption of drugs: methods and studies, Fundam Clin Pharmacol, vol.13, pp.154-168, 1999. ,
Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery, Pharm Res, vol.9, pp.969-978, 1992. ,
The potential use of receptor-mediated endocytosis for oral drug delivery, Adv Drug Deliv Rev, vol.46, pp.59-73, 2001. ,
Understanding Measurements of Intestinal Permeability in Healthy Humans with Urine Lactulose and Mannitol Excretion, Neurogastroenterol Motil, vol.22, pp.15-26, 2010. ,
Methods to determine intestinal permeability and bacterial translocation during liver disease, J Immunol Methods, vol.421, pp.44-53, 2015. ,
Investigating Gut Permeability in Animal Models of Disease, Front Physiol, vol.9, 2019. ,
A guide to Ussing chamber studies of mouse intestine, Am J Physiol Gastrointest Liver Physiol, vol.296, pp.1151-1166, 2009. ,
Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology, ALTEX, vol.32, pp.327-378, 2015. ,
Development of a primary mouse intestinal epithelial cell monolayer culture system to evaluate factors that modulate IgA transcytosis, Mucosal Immunol, vol.7, pp.818-828, 2014. ,
Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability, Gastroenterology, vol.96, pp.736-749, 1989. ,
Estimation of Solubility, Permeability, Absorption and Bioavailability. (Series: Methods and Principles in Medicinal Chemistry, vol.18, pp.146-147, 2004. ,
In vitro and in vivo models for the study of oral delivery of nanoparticles, Adv Drug Deliv Rev, vol.65, pp.800-810, 2013. ,
A fast screening model for drug permeability assessment based on native small intestinal extracellular matrix, RSC Adv, vol.8, pp.34514-34524, 2018. ,
2 -Tissue-based in vitro and ex vivo models for intestinal permeability studies, vol.4, pp.203-236, 2016. ,
Biopharmaceutical classification system: A strategic tool for oral drug delivery technology, Asian Journal of Pharmaceutics, vol.3, p.76, 2009. ,
Light-activated release of nitric oxide from vascular smooth muscle of normotensive and hypertensive rats, Biochem Biophys Res Commun, vol.200, pp.213-218, 1994. ,
The Photoactivated Relaxation of Smooth Muscle of Rabbit Aorta, J Gen Physiol, vol.44, pp.499-419, 1961. ,
Nitric Oxide and the Mechanism of Rat Vascular Smooth Muscle Photorelaxation, The Journal of Physiology, vol.550, pp.819-828, 2003. ,
Molecular mechanisms underlying the role of nitric oxide in the cardiovascular system, Expert Opinion on Investigational Drugs, vol.7, pp.1769-1779, 1998. ,
Endothelium-dependent sensory NANC vasodilatation: involvement of ATP, CGRP and a possible NO store, British Journal of Pharmacology, vol.123, pp.310-316, 1998. ,
Involvement of soluble guanylate cyclase and calcium-activated potassium channels in the long-lasting hyporesponsiveness to phenylephrine induced by nitric oxide in rat aorta, Naunyn-Schmied Arch Pharmacol, vol.361, pp.477-483, 2000. ,
Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide, Nature, vol.345, pp.161-163, 1990. ,
A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione, J Biol Chem, vol.273, pp.3264-3270, 1998. ,
NO accounts completely for the oxygenated nitrogen species generated by enzymic L-arginine oxygenation, Biochem J, vol.288, pp.597-603, 1992. ,
S-Nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase, Biochem J, vol.323, issue.2, pp.477-481, 1997. ,
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin, Proc Natl Acad Sci, vol.89, pp.7674-7677, 1992. ,
Nitrosylated bovine serum albumin derivatives as pharmacologically active nitric oxide congeners, J Pharmacol Exp Ther, vol.283, pp.947-954, 1997. ,
S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control, Nature, vol.380, pp.221-226, 1996. ,
Reactions between nitric oxide and haemoglobin under physiological conditions, Nature, vol.391, pp.169-173, 1998. ,
Nitrosyl iron complexes-synthesis, structure and biology, Dalton Trans, vol.40, pp.8273-8289, 2011. ,
Changes in Electron Spin Resonance Signals of Rat Liver During Chemical Carcinogenesis, Nature, vol.207, p.1246, 1965. ,
,
, Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR, vol.11, pp.75-80, 1988.
Factors influencing formation of dinitrosyl complexes of non-heme iron in vitro preparations of mouse liver and yeasts, Biofizika, vol.22, pp.646-650, 1977. ,
Endothelium-derived relaxing factor is a nitrosyl iron complex with thiol ligands, FEBS Letters, vol.289, pp.1-3, 1991. ,
Iron Catalyzes both Decomposition and Synthesis ofS-Nitrosothiols: Optical and Electron Paramagnetic Resonance Studies, Nitric Oxide, vol.1, pp.191-203, 1997. ,
Nitric oxide storage in the cardiovascular system, Biol Bull, vol.29, pp.477-486, 2002. ,
Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69, Nat Cell Biol, vol.4, pp.743-749, 2002. ,
S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide, J Biol Chem, vol.271, pp.19180-19185, 1996. ,
Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide, J Clin Invest, vol.103, pp.393-399, 1999. ,
Characterization of the S-denitrosation activity of protein disulfide isomerase, J Biol Chem, vol.280, pp.8733-8741, 2005. ,
Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases, J Exp Med, vol.185, pp.601-607, 1997. ,
Endothelial Dysfunction: Cardiovascular Risk Factors, Therapy, and Outcome. Vasc Health Risk Manag, vol.1, pp.183-198, 2005. ,
Endothelial dysfunction, J Am Soc Nephrol, vol.15, pp.1983-1992, 2004. ,
Nontraditional Risk Factors for Cardiovascular Disease in Diabetes, Endocr Rev, vol.25, pp.153-175, 2004. ,
The Vascular Endothelium and Human Diseases, Int J Biol Sci, vol.9, pp.1057-1069, 2013. ,
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis, Lancet, vol.340, pp.1111-1115, 1992. ,
,
, Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance, J Clin Invest, vol.97, pp.2601-2610, 1996.
, High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women, vol.98, pp.2241-2247, 1998.
Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study, Arterioscler Thromb Vasc Biol, vol.19, pp.493-498, 1999. ,
Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease, Circulation, vol.102, pp.1000-1006, 2000. ,
Predisposition to atherosclerosis by infections: role of endothelial dysfunction, Circulation, vol.106, pp.184-190, 2002. ,
Iron oxide induced enhancement of mucoadhesive potential of Eudragit RLPO: formulation, evaluation and optimization of mucoadhesive drug delivery system, Expert Opinion on Drug Delivery, vol.10, pp.1179-1191, 2013. ,
Formulation and evaluation of bilayered gastroretentable mucoadhesive patch for stomach-specific drug delivery, Current drug delivery, vol.10, pp.374-383, 2013. ,
Double emulsions prepared by twostep emulsification: History, state-of-the-art and perspective, Journal of Controlled Release, vol.295, pp.31-49, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02273441
Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery, Saudi Pharmaceutical Journal, vol.21, pp.125-141, 2013. ,
Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: Release kinetics and stability issues, Journal of Microencapsulation, vol.15, pp.699-713, 1998. ,
The effect of a water/organic solvent interface on the structural stability of lysozyme, J Control Release, vol.68, pp.351-359, 2000. ,
Biodegradable poly(lactic-co-glycolic acid) microspheres loaded with S-nitroso-N-acetyl-D-penicillamine for controlled nitric oxide delivery, J Control Release, vol.225, pp.133-139, 2016. ,
Oral Bioavailability and First-Pass Effects, Drug Metab Dispos, vol.25, pp.1329-1336, 1997. ,
Approaches for enhancing oral bioavailability of peptides and proteins, Int J Pharm, vol.447, pp.75-93, 2013. ,
Evaluation of bacterial nitrate reduction in the human oral cavity, Eur J Oral Sci, vol.113, pp.14-19, 2005. ,
Nitrate, bacteria and human health, Nat Rev Microbiol, vol.2, pp.593-602, 2004. ,
Über Nitritvergiftung nach interner Darreichung von Bismuthum subnitricum, Archiv für experimentelle Pathologie und Pharmakologie, vol.57, pp.441-454, 2005. ,
Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration, Circ Res, vol.100, pp.654-661, 2007. ,
Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control, J Clin Invest, vol.115, pp.2099-2107, 2005. ,
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation, Nat Med, vol.9, pp.1498-1505, 2003. ,
Heme proteins mediate the conversion of nitrite to nitric oxide in the vascular wall, Am J Physiol Heart Circ Physiol, vol.295, pp.499-508, 2008. ,
Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia: role for xanthine oxidoreductase and endothelial nitric oxide synthase, Circ Res, vol.103, pp.957-964, 2008. ,
Endothelial nitric oxide synthase reduces nitrite anions to NO under anoxia, Biochem Biophys Res Commun, vol.341, pp.816-821, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00094295
Human xanthine oxidase converts nitrite ions into nitric oxide (NO), Biochem Soc Trans, vol.25, p.524, 1997. ,
Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels, J Mol Cell Cardiol, vol.43, pp.437-444, 2007. ,
Nitrite-derived nitric oxide by xanthine oxidoreductase protects the liver against ischemia-reperfusion injury, HBPD INT, vol.4, pp.350-355, 2005. ,
Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage, Proc Natl Acad Sci, vol.101, pp.13683-13688, 2004. ,
Vascular responses to nitrite are mediated by xanthine oxidoreductase and mitochondrial aldehyde dehydrogenase in the rat, Can J Physiol Pharmacol, vol.87, pp.1095-1101, 2009. ,
Hypoxic modulation of exogenous nitrite-induced vasodilation in humans, Circulation, vol.117, pp.670-677, 2008. ,
Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate, Nat Med, vol.1, pp.546-551, 1995. ,
Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans, Gut, vol.40, pp.211-214, 1997. ,
Intragastric nitric oxide production in humans: measurements in expelled air, Gut, vol.35, pp.1543-1546, 1994. ,
Stomach NO synthesis, Nature, vol.368, p.502, 1994. ,
Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivates, Circ Res, vol.105, pp.1031-1040, 2009. ,
Mechanisms of nitrite reduction to nitric oxide in the heart and vessel wall, Nitric Oxide, vol.22, pp.83-90, 2010. ,
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells, Biochem Biophys Res Commun, vol.175, pp.880-885, 1991. ,
Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells, Eur J Pharm Sci, vol.10, pp.195-204, 2000. ,
Excellent Absorption Enhancing Characteristics of NO Donors for Improving the Intestinal Absorption of Poorly Absorbable Compound Compared with Conventional Absorption Enhancers, Drug Metabolism and Pharmacokinetics, vol.21, pp.222-229, 2006. ,
Improvement of intestinal absorption of macromolecules by nitric oxide donor, J Pharm Sci, vol.89, pp.1296-1304, 2000. ,
Modulation of Intestinal Permeability by Nitric Oxide Donors: Implications in Intestinal Delivery of Poorly Absorbable Drugs, J Pharmacol Exp Ther, vol.296, pp.84-90, 2001. ,
Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers, Am J Physiol, vol.268, pp.361-373, 1995. ,
In vitro models of the intestinal barrier. The report and recommendations of ECVAM Workshop 46. European Centre for the Validation of Alternative methods, Altern Lab Anim, vol.29, pp.649-668, 2001. ,
Role of S-nitrosation of cysteine residues in long-lasting inhibitory effect of nitric oxide on arterial tone, Mol Pharmacol, vol.63, pp.1148-1158, 2003. ,
LAT1 is a central transporter of essential amino acids in human umbilical vein endothelial cells, J Pharmacol Sci, vol.124, pp.511-513, 2014. ,
Activation and inhibition of soluble guanylyl cyclase by S-nitrosocysteine: involvement of amino acid transport system L, Free Radic Biol Med, vol.47, pp.269-274, 2009. ,
Oxidative stress enhances and modulates protein S-nitrosation in smooth muscle cells exposed to Snitrosoglutathione, Nitric Oxide, vol.69, pp.10-21, 2017. ,
Endothelial ?-glutamyltransferase contributes to the vasorelaxant effect of Snitrosoglutathione in rat aorta, PLoS ONE, vol.7, p.43190, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01491876
a new nitric oxide donor, induces a better vasorelaxation than other S-nitrosothiols, Eur J Pharmacol, vol.730, pp.171-179, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-00967357
Nitric oxide causes hyporeactivity to phenylephrine in isolated perfused livers from endotoxin-treated rats, Am J Physiol, vol.268, pp.177-182, 1995. ,
Inhibition of arterial contraction by dinitrosyl-iron complexes: critical role of the thiol ligand in determining rate of nitric oxide (NO) release and formation of releasable NO stores by S-nitrosation, Biochem Pharmacol, vol.66, pp.2365-2374, 2003. ,
Snitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries, J Pharmacol Exp Ther, vol.307, pp.152-159, 2003. ,
Snitrosoglutathione inhibits alpha1-adrenergic receptor-mediated vasoconstriction and ligand binding in pulmonary artery, Am J Physiol Lung Cell Mol Physiol, vol.290, pp.136-143, 2006. ,
Serine-borate complex as a transition-state inhibitor of gammaglutamyl transpeptidase, Proc Natl Acad Sci, vol.75, pp.4806-4809, 1978. ,
Glutathione-Dependent Conversion of N-Ethylmaleimide to the Maleamic Acid by Escherichia coli: an Intracellular Detoxification Process, Appl Environ Microbiol, vol.66, pp.1393-1399, 2000. ,
Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-inwater technique, Journal of Pharmacy and Pharmacology, vol.53, pp.167-178, 2001. ,
Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals, Pharmaceutics, vol.10, 2018. ,
Room Temperature Nanoparticle Drying and Low-Energy Reconstitution via Electrospinning, J Pharm Sci, vol.107, p.205, 2018. ,
Control of the morphology of nanostructured particles prepared by the spray drying of a nanoparticle sol, Journal of Colloid and Interface Science, vol.265, pp.296-303, 2003. ,
The potential of nitric oxide releasing therapies as antimicrobial agents, Virulence, vol.3, pp.271-279, 2012. ,
Nitric oxide and antimicrobial activity of reactive oxygen intermediates, Immunopharmacology, vol.37, pp.35-41, 1997. ,
Bacterial nitric oxide detoxification prevents host cell S-nitrosothiol formation: a novel mechanism of bacterial pathogenesis, FASEB J, vol.24, pp.286-295, 2010. ,
Bactericidal Effect Of Nitric Oxide Donors Against Clinical Isolates From Keratitis, Invest Ophthalmol Vis Sci, vol.52, pp.5839-5839, 2011. ,
Blood glutathione concentrations in a large-scale human study, Clin Chem, vol.42, pp.64-70, 1996. ,
BDDCS, the Rule of 5 and Drugability, Adv Drug Deliv Rev, vol.101, pp.89-98, 2016. ,
, LogP-Making Sense of the Value, p.4
Metabolic fate of Snitrosoglutathione after oral administration: Where does NO go, Nitric Oxide, vol.27, p.35, 2012. ,
Higher-energy collision-induced dissociation for the quantification by liquid chromatography/tandem ion trap mass spectrometry of nitric oxide metabolites coming from S-nitrosoglutathione in an in vitro model of the intestinal barrier, Rapid Communications in Mass Spectrometry, vol.33, pp.1-11, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02044975
Comparison between two derivatization methods of nitrite ion labeled with 15N applied to liquid chromatographytandem mass spectrometry, Anal Methods, vol.10, pp.3830-3836, 2018. ,
Nitrite in saliva increases gastric mucosal blood flow and mucus thickness, J Clin Invest, vol.113, pp.106-114, 2004. ,
Improved measurements of intracellular nitric oxide in intact microvessels using 4,5-diaminofluorescein diacetate, Am J Physiol Heart Circ Physiol, vol.301, pp.108-114, 2011. ,
Identification of Snitrosylated proteins in postmortem pork muscle using modified biotin switch method coupled with isobaric tags, Meat Sci, vol.145, pp.431-439, 2018. ,
A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response, Nitric Oxide, vol.27, pp.150-160, 2012. ,
Intratablet S-nitrosation: A New Approach for the Oral Administration of S-nitrosothiols as Nitric Oxide Donors, JPharmSci, vol.105, pp.359-361, 2016. ,
Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles, International Journal of Pharmaceutics, vol.503, pp.163-173, 2016. ,
Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery, Journal of Controlled Release, vol.225, pp.75-86, 2016. ,
Freeze concentration-induced PLGA and polystyrene nanoparticle aggregation: Imaging and rational design of lyoprotection, Journal of Controlled Release, vol.248, pp.125-132, 2017. ,
Eudragit®: a technology evaluation, Expert Opinion on Drug Delivery, vol.10, pp.131-149, 2013. ,
Pharmaceutical significance of Eudragit: A review, Future Journal of Pharmaceutical Sciences, vol.3, pp.33-45, 2017. ,
, 2225 (s), 1699 (w), 1606 (s), 1510 (s), 1646 (w), 1407 (w), 1299 (w), 1254 (s), 1176 (s, p.1036
, Curr. Pharm. Anal, issue.9, p.31, 2013.
, Eur. J. Pharm. Biopharm, vol.89, p.1, 2015.